Clinical trial

Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer

NCT00898690

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2003-03-01

PhaseN/A

Study timeline

Study start (unknown)2003-03-01Date precision: month

Registry last updated2013-12-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

cytogenetic analysisGENETIC

gene expression analysisGENETIC

microarray analysisGENETIC

mutation analysisGENETIC

reverse transcriptase-polymerase chain reactionGENETIC

immunohistochemistry staining methodOTHER

Sponsors & collaborators

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson Universitylead sponsor

National Cancer Institute (NCI)collaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00898690 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.